- Jan 31, 2009: Parag Saxena,
53, Forbes- MidasRanked #31
Parag Saxena on Forbes' 2007 Midas List
WASHINGTON, Jan 30, 2007
NRI, Parag Saxena is a seasoned venture capitalist of nearly two
decades and CEO of INVESCO Private Capital. Parag has been involved
in more than 300 private transactions, helping numerous private
companies to become public companies.
Parag led INVESCO's investments in Amgen, Argose, Amber Networks,
Centocor, DiscoveRx, Genomics Collaborative, Ishoni Networks, SmartPipes
and Xenon Genetics as well as the following investments which have
gone public: Alkermes, ARM Holdings, Celgene, Healthsouth Rehabilitation,
Indigo and Transgenomic. Parag serves on the partnership advisory
boards for Accel, Abbingworth, Essex Woodlands, Kiwi I Ventures
and Skyline Venture Partners. He is also on the board of Transgenomic
and several private company boards.
In 1983, Parag joined Citicorp Investment Management, a predecessor
firm of INVESCO. He built a $1.5 billion small-cap group with a
top-decile record prior to co-founding the private capital group.
His career began in 1978 at Becton Dickinson as a product manager.
He was later recruited by Booz, Allen and Hamilton to join their
Technology Management Services Group, focusing on business strategy
Parag received a M.B.A. from the Wharton School of the University
of Pennsylvania in 1982. He earned a B.Tech from The Indian Institute
of Technology in 1977, and a M.S. in Chemical Engineering from the
West Virginia College of Graduate Studies in 1978. He is registered
with the NASD as a General Securities Representative (Series 7).
Parag is the President of TIE (New York, New Jersey, Connecticut)
and a Trustee of the Bharatiya Vidya Bhawan (NY).
Invesco Private Capital manages $8 billion for clients around the
world and is one of the largest global venture capital and private